Format

Send to

Choose Destination
Cancer Res. 2018 Oct 15;78(20):5992-6000. doi: 10.1158/0008-5472.CAN-18-0447. Epub 2018 Aug 16.

In Vivo Estimation of Oncolytic Virus Populations within Tumors.

Author information

1
Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota.
2
College of Biological Sciences, University of Minnesota, Twin Cities, Minnesota.
3
Bioinformatics and Computational Biology Program, University of Minnesota Rochester, Rochester, Minnesota.
4
Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota. dingli.david@mayo.edu.
5
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Abstract

The use of replication-competent viruses as oncolytic agents is rapidly expanding, with several oncolytic viruses approved for cancer therapy. As responses to therapy are highly variable, understanding the dynamics of therapy is critical for optimal application of virotherapy in practice. Although mathematical models have been developed to understand the dynamics of tumor virotherapy, a scarcity of in vivo data has made difficult parametrization of these models. To tackle this problem, we studied the in vitro and in vivo spread of two oncolytic measles viruses that induce expression of the sodium iodide symporter (NIS) in cells. NIS expression enabled infected cells to concentrate radioactive isotopes that could be reproducibly and quantitatively imaged using SPECT/CT. We observed a strong linear relationship in vitro between infectious virus particles, viral N and NIS gene expression, and radioactive isotope uptake. In vivo radioisotope uptake was highly correlated with viral N and NIS gene expression. Similar expression patterns between viral N and NIS gene expression in vitro and in vivo implied that the oncolytic virus behaved similarly in both scenarios. Significant titers of viable virus were consistently isolated from tumors explanted from mice that had been injected with oncolytic measle viruses. We observed a weaker but positive in vivo relationship between radioisotope uptake and the viable virus titer recovered from tumors; this was likely due to anisotropies in the viral distribution in vivo These data suggest that methods that enable quantitation of in vivo anisotropies are required for continuing development of oncolytic virotherapy.Significance: These findings address a fundamental gap in our knowledge of oncolytic virotherapy by presenting technology that gives insight into the behavior of oncolytic viruses in vivo Cancer Res; 78(20); 5992-6000. ©2018 AACR.

PMID:
30115692
PMCID:
PMC6191353
[Available on 2019-10-15]
DOI:
10.1158/0008-5472.CAN-18-0447

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center